Health Economics


ICON's Health Economics practice delivers multi-disciplinary expertise and strategic insights grounded in the highest quality quantitative and qualitative research. Our deep experience in life sciences industries and health policy arenas enables us to tackle our clients’ most complex evidentiary and business challenges.

We provide scientifically rigorous and commercially relevant strategies and evidence that define and amplify the value of drug development, commercialisation, and health care delivery efforts. We leverage our expertise in health economics, epidemiology, patient-reported outcomes, payer engagement, pricing, and market access, to provide compelling evidence for providers, payers, and other key decision makers across the product lifecycle and in major European, North American, and key emerging markets.
Our research and guidance is scientifically credible,  actionable, and fully integrated
into the development and commercialisation process.

Project Portfolio
We explore and demonstrate value in healthcare products at key product development stages:

  • Early stage exploration of product value and investment appraisal
  • Market access and pricing
  • Reimbursement and health technology appraisal
  • Marketing and delivery of  healthcare products 

Our portfolio ranges from projects with high levels of scientific challenge to those that employ tried-and-tested methodologies.  We bring scientific rigor, and strategic insight to all our project work. We understand that credible science, elegant solutions and effective communication are crucial allies within consultancy.

Define Value Proposition

Generate and Communicate Evidence for HTAS and Payers

  • Early economic modelling
  • Value story and messaging development
  • Global Value Dossiers
  • HTA and payer evidence needs assessments
  • Economic advisory boards 
  • Cost-effectiveness analysis
  • Economic modeling
  • Systematic literature reviews and critical appraisal
  • Network meta-analysis and indirect treatment comparisons
  • HEOR strategic planning pre- and post-launch
  • Local model adaptations and reimbursement submissions
  • Peer-reviewed publications
Integration with Clinical Development Identify New Opportunities
  • Payer- and market relevant endpoints for clinical trials
  • Training solutions
  • Development of study designs and protocols
  • Regulatory and policy impact evaluation 
  • Patient and physician surveys and focus groups
  • Payer value message testing 
  • Practice pattern analyses to identify new positioning
Product Differentiation and Market Expansion  
  • Define product position 
  • Secondary database analyses 
  • Analyses of adherence, compliance, and convenience data
 

Integrated service offerings provide substantial value

At ICON, we are uniquely positioned to offer integrated services such as market access, reimbursement and marketing strategies, patient reported outcomes, epidemiology, market research and medical writing services. An integrated mulit-disciplinary service approach yields enhanced quality, efficiency, and cost savings focused on client needs.  At the same time, any of our Health Economics services may be commissioned on a stand-­‐alone basis. All of our work is conducted and delivered according to the highest quality standards with the aim of developing a professional relationship of trust and continued partnership with our clients.

Our team provides depth and breadth of expertise

Our senior management team includes opinion leading scientists and reimbursement experts with extensive experience in academia, industry, and management consulting. 

They are supported by a highly knowledgeable and enthusiastic team of 30+ senior and junior scientists who provide a wealth of research and consulting expertise that covers the full spectrum of health technology appraisal methods. Our in-company team collaborates closely with an extensive network of internationally-recognised opinion leaders, methodologists, global and nationally‐relevant market access and reimbursement experts. Our esteemed colleagues – consultants and researchers contribute importantly both to the rigor and the practical value of our work. Their academic affiliations span the globe and include: University of Oxford, University of Glasgow, University of Leicester, University of York, University of Sheffield, University of Southampton, McMaster University, University of British Columbia, UCLA, and University of Washington. We work hard to effectively integrate this diverse range of academic, commercial, and in-country expertise into our resource base.